English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

FDA signals shift toward stricter trial requirements for future CAR-T therapy approvals
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Novartis partners with Relation on AI-driven dermatology research in $1.7 billion deal
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Setbacks mark year for experimental depression drug trials
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Wave Life Sciences reports positive early results for obesity drug candidate
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Integrated strategies drive innovation in U.S. pharma manufacturing
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Patient-focused approaches may improve success rates in neuroscience drug development
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Biogen and Stoke report promising long-term seizure reduction data for Dravet syndrome drug
+ Pharmaceuticals
Patient Daily | Dec 23, 2025

Dyne Therapeutics reports strong early results for DMD exon skipping therapy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation